The Promise and Peril of the Bio-Revolution
Jan 26, 2021 & call for a public debate on how best to realize the benefits of biological innovation while mitigating the risks.
Matthias Evers
Matthias Evers is a senior partner in McKinsey’s Hamburg office and co-leads the firm’s global research and development work in the pharmaceutical and medical products practice.
Sort by:
Show:
-
The Promise and Peril of the Bio-Revolution 
-
Long Live the Bio-Revolution Long Live the Bio-Revolution
Dec 30, 2020 & tout a host of recent innovations that promise to make food systems more resilient, inclusive, and efficient.
-
COVID-19 and the Bio-Revolution COVID-19 and the Bio-Revolution
Jun 10, 2020 & illuminate the promise and perils of the current wave of biological innovation.
